This study was designed to determine the extent by which mild or moderate hypothermia attenuates the triggering of malignant hyperthermia (MH) induced by the combined administration of halothane and succinylcholine.
episode, this group of animals was exposed to 1.5 MAC halothane followed 10 min later by a 3-mg/kg bolus of succinylcholine.
MH was not induced and anesthesia was then changed to nontriggering drugs (ketamine and pancuronium).
The animals were then aggressively rewarmed to 38°C: a slight increase in the ETco, was detected, but MH episodes did not spontaneously occur. Subsequently, the readministration of halothane and succinylcholine rapidly provoked fulminant MH. We concluded that the induction of mild hypothermia impairs triggering and reduces the progression of MH induced by the combined administration of halothane and succinylcholine, whereas moderate hypothermia was completely protective and thus could be considered for prophylaxis. (Anesth Analg 1996; 82:803-9) M alignant hyperthermia (MH) is a potentially fatal genetic disorder characterized by a hypermetabolic crisis which is triggered by halogenated anesthetics and succinylcholine.
Because of the reported low incidence of MH, between 1:12000 and 1:14000 (l-51, and the known variability in clinical presentation, a complete definition of the MH phenotype has been difficult to ascertain. For example, in some patients the increase in central temperature may be slow with features of a fulminant episode taking several hours to develop, e.g., during postanesthetic recovery. Probable factors that would likely influence the clinical presentation of MH include the anesthetic administered, the age of the patient, the type of inherited genetic defect and associated genetic predisposition, the levels of circulating hormones, and the central and peripheral temperatures at the time of the anesthetic exposure. Concerning these contributing factors, it has recently been reported that: 1) newborn piglets susceptible to MH trigger MH more slowly in vim and had decreased responsiveness to halothane in uitvo when compared to more mature animals (6); 2) although changes in circulating catecholamines may enhance the onset of a MH episode induced by succinylcholine, increased catecholamine levels are not considered essential for its proliferation (7); 3) susceptibility to MH in swine affects lipid metabolism in muscle and adipose tissue to different extents relative to the breed (Retrain versus German Landrace) and gender of a given animal (unpublished observation); and 4) in susceptible swine exposed to halothane at rectal temperatures of 35, 36, and 37"C, the resultant MH-related metabolic, cardiopulmonary, and contracture responses were attenuated at the lower temperatures (9). All commonly used volatile inhalational anesthetics (halothane, isoflurane, enflurane, desflurane, sevoflurane) and depolarizing skeletal muscle relaxants will initiate the MH syndrome in genetically susceptible humans and swine (5, 10, 11 1996;82:803-9 a MH episode; halothane causes an earlier onset than either isoflurane or desflurane (10,ll). In addition, the onset of a MH episode is considered more abrupt when a volatile anesthetic and succinylcholine are used in combination (7, 12) . Thus, for the purposes of the present study the combined administration of halothane and succinylcholine was considered as one of the most potent ways to achieve anesthesia-induced MH in the porcine model.
The primary objective of the present study was to gain new insight as to the role of temperature in the initiation and proliferation of MH in viva. More specifically, we set out to determine whether the induction of mild (-35°C) or moderate (-33°C) hypothermia would be protective when acute MH was initiated by a bolus of succinylcholine, added to halothane, in a triggering sequence. Such information could provide new clinical insights to explain the variability in the presentation of this syndrome; e.g., the varied response in a given individual to a triggering anesthetic or the occurrence of MH during recovery from anesthesia.
Methods
After approval from the Institutional Animal Care and Use Committee of the University of Minnesota, the following experiments were performed on mixedbreed swine, genotypically homozygous for susceptibility to MH. Susceptibility to MH was verified by a barnyard halothane challenge, in vitro contracture testing (according to the protocol recommended by the North American Malignant Hyperthermia Registry), and linkage studies that confirmed the known substitution of cysteine for arginine 615 in the ryanodine receptor (13). Sixteen animals with average weights of 22 + 3 kg were used in these studies.
Anesthesia was induced with intravenous thiopental (administered via an ear vein) and the trachea intubated without administration of a muscle relaxant. While probes were positioned for invasive monitoring, the animals were anesthetized with 70% N,O and thiopental as needed, and were paralyzed with vecuronium (an initial 6 t 2 mg [mean + SD] bolus followed by an additional infusion of 30 t 12 mg over a 1.5-to 2-h period). Cardiac outputs were measured by thermodilution using 5 mL of cold (<2"(Z) 5% dextrose-in-water solution, injected at end-expiration (Monitor 7834 and Recorder 78576; Hewlett-Packard).
Four measurements were averaged at each time point. The heart rate was determined from a three-lead electrocardiogram (Monitor 7834 and Recorder 78576, Hewlett-Packard). The relative force output of the muscles of mastication (primarily the masseter) was monitored using a pressure transducer system calibrated before each experiment. This device (a pressure bulb) was positioned between the upper and lower molars. The signal from this unit was amplified by a Hewlett-Packard Monitor 7834. All data were collected using a LabVIEW@ program (National Instruments, Austin, TX) on a Macintosh IICi computer (Apple Computer, Inc., Cupertino, CA).
Temperatures were recorded in the distal esophagus and rectum using Mon-a-Therm@ probes (Mallinckrodt Anesthesia Products, Inc., St. Louis, MO). The electronic thermocouples were connected to a calibrated IsoThermex thermometer (Columbus Instruments, Columbus, OH), accurate to O.l"C and precise to O.Ol"C. The output of this unit was automatically recorded on a Macintosh IICi computer.
As the temperature monitoring devices were being placed, animals were either maintained normothermic (-38"C, n = 6) (same animals as in ref. 14) or had hypothermia induced to mild (=35"C, n = 6) or moderate (=33"C, n = 4) levels. To maintain normothermia, radiant heat was applied to the head and a forced-air cover positioned over the torso and lower limbs which was connected to a forced-air warming device (Bair Hugger@, Model 500; Augustine Medical, Inc.) set to deliver air at approximately 40°C. To induce hypothermia, animals were cooled using a forced-air blanket connected to a convective cooling device (a prototype unit, Augustine Medical, Inc.) which delivered air cooled to 8°C through a disposable cover. Once the targeted pulmonary artery temperature was obtained (l-2 h required to reach 35°C and 2-3.5 h for 33"C), the vecuronium infusion was stopped and no additional thiopental was administered. During a subsequent 30-min control period, ventilation was adjusted to maintain blood gases near normal values and an ETco, at 40 mm Hg. The rate and volumes of the inspired gases, which were not warmed, remained constant for the rest of the study. The arterial blood Pao,, Paco2, and pH were determined from fresh arterial samples using a blood gas analyzer with temperature compensation ( were collected prior to the administration of the triggering drugs. At the end of the control period, a nerve stimulator was used to elicit visual contractions in the forelimb muscles of each animal. All animals in each group underwent identical surgical procedures and all monitoring was the same; however, it should be noted that not all collected data was considered of value to present here (e.g., organ temperatures).
To the normothermic and mildly (-35°C) hypothermic animals, after the collection of the last set of control values, 1 minimum alveolar anesthetic concentration (MAC) (0.87%) halothane was administered followed in 5 min by an intravenous bolus of succinylcholine (2 mg/kg). The 1 MAC halothane concentration, as monitored with a gas analyzer (Nellcor), was obtained within the first 2 min by applying an initial overpressure to the vaporizer. For these two groups of animals, the administration of halothane was continued throughout the experiment until the animal died. Hemodynamic measurements, blood temperatures, and blood samples were obtained 1 min after halothane administration, and subsequently at 5-min intervals. Animals in the mildly hypothermic group which did not show signs of acute MH after 1 h of halothane administration or those whose values returned to control levels after 2 h of halothane anesthesia, were then rewarmed to approximately 38°C using forced warm air (for 30-40 min). When acute episodes of MH were triggered, animals were monitored until they died.
A different anesthetic protocol was administered to the animals that were moderately (-33°C) hypothermic. After the collection of the last set of control values these animals were administered 1.5 MAC (1.4% end-tidal; temperature corrected 1.9 MAC at 33°C) halothane was followed 10 min later by an intravenous bolus of succinylcholine (3.0 mg/kg). Hemodynamic measurements, blood temperatures, and blood samples were obtained 1 min after halothane administration, and subsequently at 5-min intervals for 1 h. At the end of this period, the halothane was shut off and during the next 30 mm, anesthesia was again maintained as needed with thiopental and vecuronium: end-tidal halothane was 0.0% before warming was initiated. Next, the animals were aggressively rewarmed, using full body forced-air warming and radiant heat directed onto the animals' heads. Active warming continued until core temperatures exceeded 37.5"C, i.e., for approximately 2.5 h. At the end of a second 30-min control period without anesthesia, halothane (1.5 MAC at 38°C) was again administered for 10 min followed by an intravenous bolus of succinylcholme (3.0 mg/kg).
The beginning of halothane administration was considered elapsed time zero. Data were analyzed using either repeated-measures analysis of variance or twotailed, unpaired or paired Student's t-tests with Bonferroni corrections as appropriate. All data are presented as mean -t SD; P < 0.05 was considered statistically significant.
Results
At the end of the 30-min control period (i.e., in which all thermal therapies were discontinued) the temperatures in the animals warmed to maintain normothermia had remained quite constant, whereas within the hypothermic groups more variability was observed. At the end of each control period, just prior to the initial administration of halothane, the average pulmonary temperatures were 37.9 + 0.3"C in the normothermic group, 34.8 t-0.6"C in the mildly hypothermic group, and 33.9 ? 0.3"C in the moderately hypothermic animals. This variability was perhaps due to the occurrence of shivering in some animals in each of the hypothermic groups (visually observed); a lack of residual paralysis was verified in each group of animals. Nevertheless, there were significant core temperature differences between the groups (P < 0.0001) prior to the administration of halothane and succinylcholine, whereas there were no differences between groups in their mean ETco2, PaoZ, Pacoz, pH, values, mean arterial blood pressure, heart rate, or cardiac output values (Tables 1 and 2 ). Blood lactate concentrations during the control period were slightly greater in the colder animals (Table 3) . MH episodes were subsequently triggered in all animals (n = 16). Figure 1 shows the posttriggering changes in ETco, for the normothermic and mildly (=35"(Z) hypothermic animals. The changes in this parameter and Pace, after halothane and succinylcholine administration were virtually uniform for the normothermic animals ( Figure 2 ), but quite variable for the animals which were mildly hypothermic ( Figure 1 and Table 1 ). All of the normothermic animals triggered within 10 min of halothane and succinylcholine administration ( Figures  1 and 2) . The individual episodes were characteristically different ( Table 1) . The time at which the ETco, was sustained at a level greater than 70 mm Hg was nearly double in the mildly hypothermic animals compared to the normothermic ones. A full blown MH episode in three of the mildly hypothermic animals did not occur until convective air warming was initiated ( Figure 1) ; in one the these animals (Animal 10 in Table 1 ) a partial episode which spontaneously subsided was observed.
Relative Effects of Mild Hypothermia (-35°C) on Episodes of MH
Administration of an intravenous bolus of succinylcholine produced substantial hypotension only in the normothermic animals ( Table 2 ). Mean arterial pressures in these swine decreased from 101 + 8 mm Hg just before succinylcholine administration to 54 + 13 mm Hg 5 min later (P < 0.001). Tachycardia was associated with the triggered MH episodes, as were significant increases in cardiac output (Table 1) . Surprisingly, cardiovascular performance was fairly well preserved even when pH, decreased to less than 6.8; arrhythmias did not become sustained and ventricular tachycardia was not a consistent feature until several minutes before death. Ventricular tachycardia was observed in 8 of 12 animals in the normothermic and mildly hypothermic groups (4 in each group) and was not detected until 14 + 12 min before death. Other organ systems failed before the heart became bradycardic, e.g., in the mildly hypothermic group, in the last 10 min before death, the ETco, decreased at a significantly faster rate than did heart rate; ETco, decreased by 44% + 33% compared to 22% 2 30% for heart rate (P < 0.05).
1996;82:803-9 MALIGNANT HYPERTHERMIA AND INDUCED HYPOTHERMIA Table   3 . Changes in Blood Chemistry After Initiation of Acute Malignant Hyperthermia (4) 8.2 t 6.6 (4)* 0.26 f 0.02 (2) Values are mean ? SD. Number of samples shown in parentheses. Blood samples were obtained before the administration of halothane (controls) and as soon as the animals ETco, reached 70 mm Hg. In several of the mildly hypothermic and in all of the moderately hypothermic animals this did not occur until subsequent forced-air rewarming. * Significantly different from normothermic animals (P < 0.05).
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Time TinEi Figure   1 . The individual changes in ETco, in the normothermic (37.9 t 0.3"C; n = 6) and mildly hypothermic (34.8 + 0.6"C; n = 6) malignant hyperthermia (MH) susceptible swine. Halothane (1 minimum alveolar anesthetic concentration) was administered at t = 0 and an intravenous bolus of succinylcholine (2 mg/kg) given at t = 5 min. Once initiated, the halothane administration was continued until the animal died. Note that changes were minimal in several of the hypothermic animals until the initiation of convective air warming as indicated by the arrows; in all three animals a fulminant MH episode followed.
In all normothermic animals, ETco, and Pace, increased rapidly after administration of halothane and succinylcholine (Figures 1 and 2 , Table 2 ). The mildly hypothermic animals also elicited fulminant MH episodes; but in three of the six animals, episodes did not occur until the animals were actively rewarmed to normothermia (Figure 1 ). There was a significant difference between these two groups of animals in the time from the administration of halothane to the time at which the ETco, = 70 mm Hg (P < 0.05; Table 1 ). Nevertheless, once an episode was triggered, severity of the symptoms in each group was similar and there were no differences between the groups in: 1) relative changes in blood gases (Table 2) ; 2) the minimum pH, values (Table 1) ; 3) maximal heart rates; or 4) changes in blood chemistry (Table 3) .
Effects of Moderate Hypothermia (-33°C) on Episodes of MH
Using convective air cooling, while anesthetized with nontriggering drugs; 2-3 h were required to decrease the central temperature of four swine to approximately 33°C. Subsequently, the administration of 1.5 MAC (1.9 MAC, temperature-corrected estimate) halothane followed 10 min later by 3 mg/kg succinylcholine did not induce episodes during 1 h of observation ( Figure 2) . However, the duration of visible fasciculations was on the order of minutes (in normothermic animals the duration ranged between 20 and 50 s; see also ref. 9). After a further 30 min of anesthesia with nontriggering drugs the animals were actively warmed using convective air therapy and radiant warming. Slight increases in both ETco, and Pace, were noted, but MH episodes were not initiated until, at a central temperature near 38"C, halothane and succinylcholine were readministered (Figure 2) . The changes in metabolic activity associated with the induced MH episodes were the same as those initiated in the other groups of animals (Table 3 ). Forty minutes after the readministration of halothane, central temperature increased by an average of 2°C in these animals.
Discussion
The combination of halothane and a bolus of succinylcholine is a potent trigger of MH in susceptible swine; however, if animals were either mildly (-35°C) or moderately (=33"C) hypothermic, their effectiveness as triggering drugs was reduced or eliminated. Nevertheless, when nontrigger animals were returned to In general, the observations reported here are consistent with the previous report by Nelson (9), in 1990, who observed that mild hypothermia attenuated metabolic, cardiopulmonary, and contracture responses in susceptible swine exposed only to halothane. However, in that study, the effects of mild hypothermia on MH were investigated at temperatures of 37, 36, and 35°C; hence, all animals might be considered mildly hypothermic and no normothermic group was investigated. Furthermore, rectal temperatures were used as the only indicator of hyperthermia.
In this and a recent study (141, we observed that rectal temperatures were poorly correlated with the other core measurements during the latter stages of the MH crises. Nevertheless, the present data are in agreement with Nelson's conclusion that the effects of mild hypothermia on MH may be one important environmental factor determining the incidence and magnitude of acute MH. This conclusion can now be extended to state that even with a more rigorous MH challenge (the combined use of halothane and succinylcholine) moderate or mild hypothermia can be considered protective and could be considered for prophylaxis in patients thought to be susceptible to MH. One advantage of this approach is that the negative side effects of dantrolene prophylaxis could be avoided (15); however, this later approach has become less common. It is likely that even in the normothermic individual, the ability to trigger a MH event may be reduced if the peripheral compartments are significantly cool, i.e., the extent of the core area which is normothermic is minimized and subsequent redistribution of blood flow during the administration of a volatile anesthetic will rapidly result in a mildly hypothermic state. Fulminant episodes of MH were subsequently induced by rewarming the mildly hypothermic animals in which the halothane administration was continuous. Hence, temperature-dependent triggering may help to explain the following events: 1) an individual who does not elicit a fulminant episode of MH on one exposure to triggering drugs, but does so upon next exposure; 2) the initiation of an episode of MH in the postanesthetic recovery area, perhaps in part due to the stress of active rewarming; and 3) the potential for the recrudescence of MH. These findings may also partially explain why the incidence of MH is higher in infants and children under anesthesia, who are more often kept normothermic, than in adults, who are often allowed to become hypothermic.
We studied swine because they are the standard model of MH and because the physiological responses to triggering drugs are comparable in pigs and humans. Similarly, pigs are considered a useful model in thermoregulatory research because their behavioral and autonomic responses reflect those of humans. However, susceptibility to MH in swine is considered to be due to a single-point mutation (13), whereas in humans it is heterogenetic (4) . Thus, the temperaturedependence for MH triggering in humans could differ somewhat among individuals with different mutations causing this syndrome.
